Exhibit 99.2

1.75% Convertible Senior Notes due 2018

and

U.S. Bank National Association

633 West Fifth Street, 24th Floor

Los Angeles, California 90071

Attention: Paula Oswald (Emulex Corporation 1.75% Notes due 2018)

Reference is hereby made to the Indenture, dated as of November 18, 2013 (as amended or supplemented from time to time, the “Indenture”), between Emulex Corporation, a Delaware corporation (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”), relating to the Company’s 1.75% Convertible Senior Notes due 2018 (CUSIP No. 292475AF7) (the “Notes”). Capitalized terms used but not defined in this notice shall have the meanings ascribed to such terms in the Indenture. A copy of the Indenture was filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on November 21, 2013.

On February 25, 2015, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Avago Technologies Wireless (U.S.A.) Manufacturing Inc. (“Parent”), a Delaware corporation and wholly owned subsidiary of Avago Technologies Limited (“Avago”), and Emerald Merger Sub, Inc. (“Purchaser”), a Delaware corporation and a wholly owned subsidiary of Parent. A copy of the press release publicly announcing the execution of the Merger Agreement and a copy of the Merger Agreement were filed as exhibits to the Company’s Current Report on Form 8-K filed with the SEC on February 25, 2015 and February 26, 2015, respectively.

Pursuant to the terms and conditions of the Merger Agreement, Purchaser commenced a tender offer (the “Offer”) on April 7, 2015 to purchase all of the outstanding shares of common stock of the Company, par value $0.10 per share (“Company Common Stock”) (which shares of Company Common Stock, are hereinafter referred to as the “Shares”), at a price of $8.00 per Share, payable net to the holder thereof in cash, without interest (such amount, the “Offer Price”), subject to any withholding of taxes required by applicable law. Purchaser consummated the Offer on May 5, 2015.

Following the consummation of the Offer, pursuant to the terms and conditions set forth in the Merger Agreement, on May 5, 2015, Purchaser merged with and into the Company, with the Company as the surviving corporation in the merger (the “Merger”), and each Share issued and outstanding immediately prior to the effective time of the Merger (other than (i) Shares held by Parent or any of its Subsidiaries, including Purchaser, or in the treasury of the Company to be cancelled pursuant to the Merger Agreement and (ii) Shares held by stockholders who properly exercised appraisal rights with respect to such Shares under Delaware law) was converted into the right to receive the Offer Price, payable net to the holder thereof in cash, without interest, subject to any withholding of taxes required by applicable law.

The consummation of the Merger constitutes a Merger Event, and the consummation of the Offer and the Merger constitutes a Fundamental Change and a Make-Whole Fundamental Change, under the Indenture. The Effective Date of each of the Merger Event and the Fundamental Change and the Effective Date of the Make-Whole Fundamental Change is May 5, 2015, the date of the consummation of the Offer and the Merger. As described below, the Indenture provides that, as a result of the Merger Event, the Company and the Trustee shall execute a supplemental indenture permitted under Section 8.01(c) of the Indenture to change each Holder’s right to convert Notes for cash and shares into a right (but not the obligation) to convert Notes for the Reference Property, which in this case will be the cash Offer Price per share. The Indenture further provides that, as a result of the Fundamental Change, each Holder of the Notes shall have the right to either require the Company to purchase its Notes or, alternatively, to surrender its Notes for conversion. In addition, as a result of the Make-Whole Fundamental Change, Holders who convert their Notes during the Make-Whole Fundamental Change Period (defined below) shall be entitled to convert their Notes at an increased conversion rate.

You should review this notice carefully and consult with your own financial, tax and legal advisors. You must make your own decision as to whether or not to surrender your Notes for purchase by the Company or to exercise your conversion rights, if at all, and, if so, the amount of Notes to surrender or convert. None of the Company, Parent, Purchaser, the Trustee, the Paying Agent, the Conversion Agent or any of their respective affiliates is making any representation or recommendation to any Holder as to whether Holders should elect to require the Company to purchase their Notes or convert their Notes.

Notice of Merger Event, Record Date and Effective Date of the Merger and Date on which

Holders are Entitled to Exchange Shares for Reference Property

The Merger constitutes a Merger Event under Section 4.07(a) of the Indenture. The date as of which the holders of Company Common Stock of record were determined for purposes of the Merger, the date on which the Merger became effective and the date as of which holders of Company Common Stock became entitled to exchange their Shares for the Reference Property as a result of the Merger is May 5, 2015.

SUPPLEMENTAL INDENTURE

Notice of Execution of Supplemental Indenture

Section 4.07 of the Indenture provides that, in connection with and as a result of the Merger, from and after 9:00 A.M. (Eastern) on May 5, 2015, the effective time of the Merger (the “Effective Time”), the right to convert each $1,000 in principal amount of Notes shall be changed into a right to convert such principal amount of Notes into the kind and amount of shares of stock, other securities or other property or assets (including cash or any combination thereof) that a holder of a number of shares of Company Common Stock equal to the Conversion Rate immediately prior to such Merger Event would have owned or been entitled to receive upon such Merger Event, and that prior to or at the effective time of such Merger Event, the Company or the successor purchasing Person, as the case may be, shall execute with the Trustee a supplemental indenture permitted under Section 8.01(c) providing for such change in the right to convert each $1,000 principal amount of Notes.

2

On May 5, 2015, the Company and the Trustee executed a supplemental indenture (the “Supplemental Indenture”) permitted under Section 8.01(c) of the Indenture and required by Section 4.07 of the Indenture as described above. The Supplemental Indenture provides that for all conversions that occur after the Effective Time in accordance with and subject to Article 4 of the Indenture, the consideration due upon conversion of each $1,000 principal amount of Notes shall be solely cash in an amount equal to the Conversion Rate in effect on the Conversion Date (as may be increased pursuant to Section 4.06 of the Indenture, as described below under “Conversion Right—Conversion Rate and Make-Whole Adjustment”), multiplied by $8.00 per share, the Offer Price, less any applicable withholding taxes, and that the Company shall make such cash payment to converting Holders on the third Business Day immediately following the Conversion Date.

A copy of the Supplemental Indenture was filed by the Company with the SEC as an exhibit to a Current Report on Form 8-K dated May 5, 2015.

FUNDAMENTAL CHANGE PURCHASE RIGHT

Notice of Effective Date of Fundamental Change, Fundamental Change Purchase Date

and Fundamental Change Purchase Price

The effective date of the Fundamental Change resulting from the consummation of the Offer and the Merger is May 5, 2015. Pursuant to Section 3.01 of the Indenture, on July 1, 2015 (the “Fundamental Change Purchase Date”), each Holder has the right, at the Holder’s option, to require the Company to purchase for cash all of such Holder’s Notes, or any portion thereof that is a multiple of $1,000 principal amount, on the Fundamental Change Purchase Date, in accordance with and subject to the satisfaction of the Holder of the requirements set forth in Section 3.01 of the Indenture. The Company will purchase such Notes at a price (the “Fundamental Change Purchase Price”) equal to 100% of the principal amount of such Notes, plus any accrued and unpaid interest thereon, to, but excluding, the Fundamental Change Purchase Date.

In order to exercise the right to require the Company to purchase a Holder’s Notes, the Holder must surrender such Notes on or prior to the close of business on June 30, 2015, the Business Day immediately preceding the Fundamental Change Purchase Date. In order to withdraw Notes that have been previously surrendered for purchase, the Holder must submit a withdrawal notice on or prior to the close of business (5:00 P.M. New York City time) on June 30, 2015.

IMPORTANT: The Fundamental Change Purchase Price that you will receive if you validly exercise the Fundamental Change Purchase Right will be substantially less than the value that you would receive upon conversion of the Notes, as described below under “Conversion Right—Conversion Rate and Make-Whole Adjustment.”

Purchase Procedures

The Trustee has informed the Company that, as of the date of this notice, The Depository Trust Company (the “Depositary”) is the sole registered Holder of the Notes, all custodians and beneficial holders of the Notes hold the Notes through Depositary accounts and there are no Physical Notes. Under Section 3.03 of the Indenture, to surrender for purchase a beneficial interest in a Note represented by a Global Note, the Holder must, in addition to complying with any other rules and procedures of the Depositary, deliver by book-entry transfer to the Paying Agent in compliance with the procedures of the Depositary, the interest in the Global Note to be purchased.

3

The Paying Agent and Conversion Agent is: U.S. Bank National Association

The Trustee is acting as the Paying Agent and Conversion Agent, and its address and telephone number are as follows:

U.S. Bank West Side Flats Operations Center

Corporate Trust Services

Specialized Finance

111 Fillmore Ave E, EP-MN-WS1P

St. Paul, Minnesota 55107-1402

cts.specfinance@usbank.com

Telephone: 1-800-936-6802

Copies of this notice may be obtained from the Paying Agent and Conversion Agent at its address set forth above.

Further information about the Fundamental Change Purchase Price and the procedures a Holder must follow to tender Notes for purchase by the Company or withdraw a Fundamental Change Purchase Notice is contained in the Company’s Offer to Purchase, dated May 12, 2015 (the “Offer to Purchase”), which is being distributed to Holders under separate cover. A copy of the Form of Fundamental Change Purchase Notice is attached hereto as Appendix A.

CONVERSION RIGHT

Notice of Effective Date of Make-Whole Fundamental Change, Make-Whole Fundamental

Change Period, Conversion Rate and Make-Whole Adjustment

The Effective Date of the Make-Whole Fundamental Change resulting from the consummation of the Offer and the Merger is May 5, 2015. As an alternative to requiring the Company to purchase a Holder’s Notes, the Notes may be surrendered for conversion at any time from and after April 9, 2015 until the close of business (5:00 P.M. New York City time) June 30, 2015, the Business Day immediately preceding the Fundamental Change Purchase Date, in accordance with Section 4.06(a) of the Indenture. In addition, in accordance with Section 4.07 of the Indenture and Section 2.01 of the Supplemental Indenture, Holders who surrender their Notes for conversion from and after the Effective Time will receive solely cash in an amount equal to the Conversion Rate in effect on the Conversion Date, multiplied by $8.00, the Offer Price per Share, less any applicable withholding taxes, and will not receive any shares of Company Common Stock.

Any Notes with respect to which a Fundamental Change Purchase Notice has been delivered by a Holder may be converted only if the Holder withdraws the Fundamental Change Purchase Notice in accordance with the terms of the Indenture.

Conversion Rate and Make-Whole Adjustment

The Conversion Rate in effect immediately prior to the Make-Whole Fundamental Change is 97.1322 shares of Company Common Stock per $1,000 principal amount of Notes (the “Base Conversion Rate”), which equates to a Conversion Price of approximately $10.30 per Share. The Conversion Rate applicable to Notes that are surrendered for conversion during the period following the Effective Date of the Make-Whole Fundamental Change and ending at 5:00 p.m., New York City time, on June 30, 2015, the Business Day immediately preceding the

4

Fundamental Change Purchase Date (such period, the “Make-Whole Fundamental Change Period”), will be increased pursuant to Section 4.06 of the Indenture (such increased Conversion Rate, the “Make-Whole Conversion Rate”). The number of Additional Shares to be received per $1,000 principal amount of Notes pursuant to Section 4.06 of the Indenture during the Make-Whole Fundamental Change Period is 29.8639 shares of Company Common Stock. Accordingly, during the Make-Whole Fundamental Change Period, the Make-Whole Conversion Rate is 126.9961 shares of Company Common Stock per $1,000 principal amount of Notes, which equates to an Make-Whole Conversion Price of approximately $7.87 per Share.

Upon the expiration of the Make-Whole Fundamental Change Period, the Conversion Rate will automatically, without further notice, return to the Base Conversion Rate. Accordingly, if any Holder fails to convert its Notes during the Make-Whole Fundamental Change Period, that Holder will lose its right to convert its Notes at the increased Make-Whole Conversion Rate, and the Notes will no longer be convertible unless and until another conversion trigger occurs.

The following table illustrates the approximate amount in cash per $1,000 principal amount of Notes that a Holder would receive if its Notes are (a) purchased by the Company through exercise of the Fundamental Change Purchase Right, (b) converted during the Make-Whole Fundamental Change Period at the Make-Whole Conversion Rate from and after the Effective Time or (c) converted at the Base Conversion Rate.

Contact information for the Conversion Agent is set forth above under “Fundamental Change Purchase Right.” Further information about the procedures that Holders must follow to convert their Notes, including information about interest payments and backup withholding, is contained in the Offer to Purchase and incorporated herein by reference. A copy of the Form of Notice of Conversion is attached hereto as Appendix B.

WHERE YOU CAN FIND ADDITIONAL INFORMATION

The Company is in the process of requesting suspension of its reporting obligations under Sections 13 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Prior to the date of this notice, the Company filed annual, quarterly and current reports, proxy statements and other information with the SEC. The Company’s SEC filings may be read and copied at the SEC’s public reference room located at 100 F Street, N.E., Washington, D.C., 20549. The Company’s SEC filings also are available to the public at the SEC’s website at http://www.sec.gov.

The documents listed below (as they may be amended from time to time) contain important information about the Company and the Notes, and Holders should review these documents carefully before determining whether or not to convert their Notes as described in this notice:

5

For more information about the Offer and the Merger, Holders should review the Schedule TO filed by Avago, Parent and Purchaser on April 7, 2015 and the Schedule 14D-9 filed by the Company with the SEC on April 7, 2015, each as subsequently amended or supplemented. A copy of the Merger Agreement was filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 26, 2015.

In the event of conflicting information in the documents referred to above, the information in the latest filed documents should be considered correct. Holders should not assume that the information in this notice or any of the documents referred to above is accurate as of any date other than the date of the applicable document.

EMULEX CORPORATION

May 12, 2015

*******

Forward-Looking Statements

Certain statements either contained in or incorporated by reference into this communication, other than purely historical information, including estimates, projections and statements relating to the Company’s, Parent’s or Avago’s respective business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements.” These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. The forward-looking statements contained in this document are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Factors which could cause actual results to differ from those projected or contemplated in any such forward-looking statements include, but are not limited to, the following factors: risks that the proposed

6

transaction disrupts the current plans and operations of the Company, Parent or Avago; the ability of the Company to retain and hire key personnel; competitive responses to the proposed transaction; unexpected costs, charges or expenses resulting from the transaction; potential adverse reactions or changes to business relationships resulting from the announcement or completion of the transaction; Avago’s ability to achieve the growth prospects and synergies expected from the transaction, as well as delays, challenges and expenses associated with integrating the Company with its existing businesses; and legislative, regulatory and economic developments. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the risks detailed in the Company’s public filings with the SEC from time to time, including the Company’s most recent Annual Report on Form 10-K for the year ended June 29, 2014 (as amended), and the Company’s subsequent Quarterly Report on Form 10-Q for the three months ended March 29, 2015. The reader is cautioned not to unduly rely on these forward-looking statements. The Company expressly disclaims any intent or obligation to update or revise publicly these forward-looking statements except as required by law.

7

Appendix A

FORM OF FUNDAMENTAL CHANGE PURCHASE NOTICE

To: Emulex Corporation

The undersigned registered owner of this Note hereby acknowledges receipt of a notice from Emulex Corporation (the “Company”) as to the occurrence of a Fundamental Change with respect to the Company and specifying the Fundamental Change Purchase Date and requests and instructs the Company to pay to the registered holder hereof in accordance with the applicable provisions of the Indenture referred to in this Note (i) the entire principal amount of this Note, or the portion thereof (that is such that the portion not to be purchased has a principal amount equal to $1,000 or an integral multiple of $1,000 in excess thereof) below designated, and (ii) if such Fundamental Change Purchase Date does not occur during the period after a Regular Record Date and on or prior to the Interest Payment Date corresponding to such Regular Record Date, accrued and unpaid interest, if any, thereon to, but excluding, such Fundamental Change Purchase Date.

Principal amount to be repaid (if less than all):

$                             

Dated:                                     

A-1

METHOD OF DELIVERY

Name of Surrendering Institution:

DTC Account Number:

Contact Person:

Address:

Telephone (with international dialing code):

Facsimile (with international dialing code):

Date Surrendered:

Transaction Code Number:

SPECIAL ISSUANCE INSTRUCTIONS

To be completed ONLY if payments are to be made to Depositary for the account of someone other than the person(s) whose signature appear(s) within this purchase notice.

Make payment to:

A-2

Appendix B

FORM OF NOTICE OF CONVERSION

To: Emulex Corporation

The undersigned owner of this Note hereby irrevocably exercises the option to convert this Note, or a portion hereof (which is such that the principal amount of the portion of this Note that will not be converted equals $1,000 or an integral multiple of $1,000 in excess thereof) below designated, into an amount of cash and, if applicable, shares of Common Stock in accordance with the terms of the Indenture referred to in this Note, and directs that any cash payable and any shares of Common Stock issuable and deliverable upon conversion, together with any Notes representing any unconverted principal amount hereof, be paid and/or issued and/or delivered, as the case may be, to the registered Holder hereof unless a different name is indicated below.

Subject to certain exceptions set forth in the Indenture, if this notice is being delivered on a date after the Close of Business on a Regular Record Date and prior to the Open of Business on the Interest Payment Date corresponding to such Regular Record Date, this notice must be accompanied by payment of an amount equal to the interest payable on such Interest Payment Date on the principal amount of this Note to be converted. If any shares of Common Stock are to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect to such issuance and transfer as set forth in the Indenture.

Principal amount to be converted (if less than all):

$                             

Dated:                                     

B-1

Fill in if a check is to be issued, or shares of Common Stock or Notes are to be registered, otherwise than to or in the name of the registered Holder.

(Social Security or Other Taxpayer Identifying Number)

B-2

METHOD OF DELIVERY

Name of Surrendering Institution:

DTC Account Number:

Contact Person:

Address:

Telephone (with international dialing code):

Facsimile (with international dialing code):

Date Surrendered:

Transaction Code Number:

SPECIAL ISSUANCE INSTRUCTIONS

To be completed ONLY if payments are to be made to Depositary for the account of someone other than the person(s) whose signature appear(s) within this conversion notice.

Make payment to:

B-3